Document:

KBS SOR II Q2 2014 Exhibit 4.2

Exhibit 4.2
STATEMENT REGARDING RESTRICTIONS ON
TRANSFERABILITY OF SHARES OF COMMON STOCK
(To Appear on Stock Certificate or to Be Sent upon Request
and without Charge to Stockholders Issued Shares without Certificates)
The shares represented by this certificate are subject to restrictions on Beneficial Ownership, Constructive Ownership and Transfer for the purpose of the Corporation’s maintenance of its status as a Real Estate Investment Trust under the Internal Revenue Code of 1986, as amended (the “Code”). Subject to certain further restrictions and except as expressly provided in the Corporation’s charter: (a) no Person may Beneficially Own or Constructively Own shares of the Corporation’s Common Stock in excess of 9.8% (in value or number of shares) of the outstanding shares of Common Stock of the Corporation unless such Person is an Excepted Holder (in which case the Excepted Holder Limit for such Excepted Holder shall be applicable); (b) no Person may Beneficially Own or Constructively Own shares of Capital Stock of the Corporation in excess of 9.8% of the value of the total outstanding shares of Capital Stock of the Corporation, unless such Person is an Excepted Holder (in which case the Excepted Holder Limit for such Excepted Holder shall be applicable); (c) no Person may Beneficially Own or Constructively Own Capital Stock that would result in the Corporation being “closely held” under Section 856(h) of the Code or otherwise cause the Corporation to fail to qualify as a REIT; and (d) no Person may Transfer shares of Capital Stock if such Transfer would result in the Capital Stock of the Corporation being owned by fewer than 100 Persons. Any Person who Beneficially Owns or Constructively Owns or attempts to Beneficially Own or Constructively Own shares of Capital Stock that causes or will cause a Person to Beneficially Own or Constructively Own shares of Capital Stock in excess or in violation of the above limitations must immediately notify the Corporation or, in the case of a proposed or attempted transaction, give at least 15 days prior written notice and provide to the Corporation such other information as the Corporation may request in order to determine the effect, if any, of such Transfer on the Corporation’s status as a REIT. If any of the restrictions on Transfer or ownership are violated, the shares of Capital Stock represented hereby will be automatically transferred to a Trustee of a Trust for the benefit of one or more Charitable Beneficiaries.  In addition, the Corporation may redeem shares of Capital Stock upon the terms and conditions specified by the board of directors in its sole discretion if the board of directors determines that ownership or a Transfer or other event may violate the restrictions described above. Furthermore, upon the occurrence of certain events, attempted Transfers in violation of the restrictions described above may be void ab initio.
Until the Common Stock is Listed, to purchase Common Stock, the purchaser must represent to the Corporation: (i) that such purchaser (or, in the case of sales to fiduciary accounts, that the beneficiary, fiduciary account or grantor or donor who directly or indirectly supplies the funds to purchase the shares if the grantor or donor is the fiduciary) has a minimum annual gross income of $70,000 and a net worth (excluding home, home furnishings and automobiles) of not less than $70,000; (ii) that such purchaser (or, in the case of sales to fiduciary accounts, that the beneficiary, fiduciary account or grantor or donor who directly or indirectly supplies the funds to purchase the shares if the grantor or donor is the fiduciary) has a net worth (excluding home, home furnishings and automobiles) of not less than $250,000; and/ or (iii) that the purchaser (or, in the case of sales to fiduciary accounts, that the beneficiary, fiduciary account or grantor or donor who directly or indirectly supplies the funds to purchase the shares if the grantor or donor 

is the fiduciary) meets the more stringent suitability standards of such person’s jurisdiction as set forth in any then effective registration statement of the Corporation as such registration statement has been amended or supplemented as of the date of such purchase. Until the Common Stock is Listed, unless a stockholder is transferring all of his shares of Common Stock, each issuance or transfer of shares of Common Stock for value shall comply with the requirements regarding minimum initial and subsequent cash investment amounts set forth in any then effective registration statement of the Corporation as such registration statement has been amended or supplemented as of the date of such issuance or transfer for value or any higher or lower applicable state requirements with respect to minimum initial and subsequent cash investment amounts in effect as of the date of the issuance or transfer. 
All capitalized terms in this legend have the meanings defined in the charter of the Corporation, as the same may be amended from time to time, a copy of which, including the restrictions on Transfer and ownership, will be furnished to each holder of Capital Stock of the Corporation on request and without charge. 
Note: Instead of the foregoing legend, the certificate may state that the Corporation will furnish to a stockholder on request and without charge a full statement about certain restrictions on transferability.EX-4.1

 Exhibit 4.1 

HORIZON PHARMA, INC., 
 HORIZON
PHARMA PUBLIC LIMITED COMPANY 
 AND 

U.S. BANK NATIONAL ASSOCIATION, 

as Trustee 
 FIRST SUPPLEMENTAL
INDENTURE 
 Dated as of September 19, 2014 

5.00% Convertible Senior Notes due 2018 

 FIRST SUPPLEMENTAL INDENTURE, dated as of September 19, 2014 (this “Supplemental
Indenture”), among HORIZON PHARMA, INC., a Delaware corporation (the “Company”), HORIZON PHARMA PUBLIC LIMITED COMPANY, a public limited company organized under the laws of Ireland (f/k/a Vidara Thereapeutics International
Public Limited Company; f/k/a Vidara Therapeutics International Limited) (“Guarantor”), and U.S. BANK NATIONAL ASSOCIATION, a national banking association, as trustee (the “Trustee”), to the Indenture, dated as of
November 22, 2013 (the “Indenture”), between the Company and the Trustee. 
 WHEREAS, the Company has heretofore
executed and delivered the Indenture, pursuant to which the Company issued its 5.00% Convertible Senior Notes due 2018 (the “Notes”) in the original aggregate principal amount of $150,000,000, convertible under certain circumstances
into cash and/or shares of the Company’s common stock, par value $0.0001 per share (“Company Common Stock”), at the Company’s option; 

WHEREAS, pursuant to the Transaction Agreement and Plan of Merger, dated as of March 18, 2014 (as amended, supplemented, restated or
otherwise modified, the “Merger Agreement”), by and among the Company, Vidara Therapeutics Holdings LLC, a Delaware limited liability company, Guarantor, Hamilton Holdings (USA), Inc., a Delaware corporation, and Hamilton Merger
Sub, Inc., a Delaware corporation, the Company will become a wholly-owned subsidiary of Guarantor (the “Merger”) upon the consummation of the Merger (the “Closing”) contemplated thereby as of the date hereof; 

WHEREAS, the Merger constitutes a Merger Event under the Indenture and Section 14.07 of the Indenture provides that in the case of any
Merger Event, then, at and after the effective time of such Merger Event, as a condition precedent to such transaction, the Company shall execute and deliver to the Trustee a supplemental indenture permitted under Section 10.01(f) of the
Indenture providing that the right to convert each $1,000 principal amount of Notes shall be changed into a right to convert such principal amount of Notes into Reference Property upon such Merger Event; 

WHEREAS, pursuant to Section 14.07 of the Indenture, if the Reference Property includes shares of stock, securities or other property or
assets (including cash or any combination thereof) of a Person other than the successor or purchasing corporation, as the case may be, in such Merger Event, then such supplemental indenture shall also be executed by such other Person and shall
contain such additional provisions to protect the interests of the Holders of the Notes as the Board of Directors shall reasonably consider necessary by reason of the foregoing, including, to the extent required by the Board of Directors and
practicable, the provisions providing for the purchase rights set forth in Article 15 of the Indenture; 
 WHEREAS, in connection with the
Merger, each outstanding share of Company Common Stock has been converted into the right to receive one ordinary share, par value $0.0001 per share, in capital of Guarantor (“Guarantor Common Stock”) in accordance with the terms of
the Merger Agreement; 
 WHEREAS, from and after the effective time of the Merger, Guarantor desires to fully and unconditionally guarantee
all of the payment obligations of the Company under the Notes and the Indenture so as to make available the exemption from the registration requirements of the Securities Act of 1933, as amended (the “Act”), provided by
Section 3(a)(9) of the Act for shares of Guarantor Common Stock delivered upon conversion of the Notes following the Merger; 

WHEREAS, pursuant to Section 10.01 of the Indenture, the Company and the Trustee may enter into indentures supplemental to the Indenture
to, among other things, make any change (i) to add guarantees with respect to the Notes, (ii) to make any change that does not adversely affect the rights of any Holder, or (iii) in connection with any Merger Event, provide that the
Notes are convertible into 

  
 2. 

 
Reference Property, subject to the provisions of Section 14.02, and make such related changes to the terms of the Notes to the extent expressly required by Section 14.07; 

WHEREAS, a dully authorized committee of the Board of Directors of the Company has duly authorized this Supplemental Indenture by resolutions
adopted on September 14, 2014, and the entry into this Supplemental Indenture by the parties hereto is permitted by the provisions of the Indenture; 

WHEREAS, in connection with the execution and delivery of this Supplemental Indenture, the Trustee has received an Officer’s Certificate
and an Opinion of Counsel as contemplated by Section 17.05 of the Indenture; and 
 WHEREAS, the Company and Guarantor have requested
that the Trustee execute and deliver this Supplemental Indenture and have satisfied all requirements necessary to make this Supplemental Indenture a valid instrument in accordance with its terms. 

WITNESSETH: 
 NOW THEREFORE, each
party agrees as follows for the benefit of the other parties and for the equal and ratable benefit of the Holders: 
 ARTICLE 1 

DEFINITIONS 
 Section 1.01.
Definitions in the Supplemental Indenture. Unless otherwise specified herein or the context otherwise requires: 
 (a) a term
defined in the Indenture has the same meaning when used in this Supplemental Indenture unless the definition of such term is amended or supplemented pursuant to this Supplemental Indenture; 

(b) the terms defined in this Article and in this Supplemental Indenture include the plural as well as the singular; 

(c) unless otherwise stated, a reference to a Section or Article is to a Section or Article of this Supplemental Indenture; and 

(d) Article and Section headings herein are for convenience only and shall not affect the construction hereof. 

Section 1.02. Definitions in the Indenture.  

(a) The Indenture is hereby amended and supplemented by adding the following additional definitions to Section 1.01 of the Indenture in
the appropriate alphabetical order. 
 “Closing” means the effective date of the merger contemplated in that certain
Transaction Agreement and Plan of Merger, dated as of March 18, 2014 (as amended, supplemented, restated or otherwise modified), by and among the Company, Vidara Therapeutics Holdings LLC, a Delaware limited liability company, Vidara
Therapeutics International Limited, an Irish private limited company, Hamilton Holdings (USA), Inc., a Delaware corporation, and Hamilton Merger Sub, Inc., a Delaware corporation, the Company will become a wholly-owned subsidiary of the Guarantor.

  
 3. 

 “First Supplemental Indenture” means that certain Supplemental Indenture, dated
as of September 19, 2014, by and among the Company, the Guarantor and the Trustee. 
 “Guarantor” means Horizon Pharma
Public Limited Company, a public limited company organized under the laws of Ireland (f/k/a Vidara Therapeutics International Public Limited Company; f/k/a Vidara Therapeutics International Limited). 

“Guarantee Obligations” has the meaning set forth in Section 3.01 of the First Supplemental Indenture. 

“Note Guarantee” means the Guarantee by the Guarantor of the payment or performance of the Company’s obligations under
this Indenture and the Notes pursuant to Article 3 of the First Supplemental Indenture. 
 (b) The Indenture is hereby amended by replacing
the defined terms “Board of Directors”, “Board Resolutions”, “Common Stock”. “Fundamental Change”, “Officer” and “Officer’s Certificate” in their entirety with the following terms:

 “Board of Directors” means the board of directors of the Company or, for purposes of Article 14, the Guarantor, or a
committee of such board duly authorized to act for it hereunder. 
 “Board Resolution” means a copy of a resolution
certified by the Secretary or an Assistant Secretary of the Company or the Guarantor, as applicable, to have been duly adopted by the Board of Directors, and to be in full force and effect on the date of such certification, and delivered to the
Trustee. 
 “Common Stock” means the ordinary shares, par value $0.0001 per share, in capital of the Guarantor, at the date
of the Closing, subject to Section 14.07. 
 “Fundamental Change” shall be deemed to have occurred at the time after
the Notes are originally issued if any of the following occurs: 
 (a) a “person” or “group” within the
meaning of Section 13(d) of the Exchange Act, other than in the case of the Guarantor, the Guarantor, its Wholly Owned Subsidiaries and the employee benefit plans of the Guarantor and its Wholly Owned Subsidiaries and, other than in the case of
the Company, the Company, its Wholly Owned Subsidiaries and the employee benefit plans of the Company and its Wholly Owned Subsidiaries, files a Schedule TO or any schedule, form or report under the Exchange Act disclosing that such person or group
has become the direct or indirect “beneficial owner,” as defined in Rule 13d-3 under the Exchange Act, of the Guarantor’s or the Company’s Common Equity representing more than 50% of the voting power of the Guarantor’s or
the Company’s Common Equity; 
 (b) the consummation of (A) any recapitalization, reclassification or change of the
Common Stock (other than changes resulting from a subdivision or combination) as a result of which the Common Stock would be converted into, or exchanged for, stock, other securities, other property or assets; (B) any share exchange,
consolidation or merger of the Guarantor or the Company pursuant to which the Common Stock will be converted into cash, securities or other property or assets, other than a merger of the Guarantor or the Company, as applicable, solely for the
purpose of changing the Guarantor’s or the Company’s, as applicable, jurisdiction of incorporation that results in a reclassification, conversion or exchange of outstanding shares of Common Stock solely into shares of common stock of the
surviving entity; or (C) any sale, lease or other transfer in one transaction or a series of transactions of all or substantially all of the consolidated assets of the Guarantor and its 

  
 4. 

 
Subsidiaries, taken as a whole, to any Person other than one of the Guarantor’s direct or indirect Wholly Owned Subsidiaries; provided, however, that a transaction described in clause
(A) or clause (B) in which the holders of all classes of the Guarantor’s or the Company’s, as applicable, Common Equity immediately prior to such transaction own, directly or indirectly, more than 50% of all classes of Common
Equity of the continuing or surviving corporation or transferee or the parent thereof immediately after such transaction in substantially the same proportions (relative to each other) as such ownership immediately prior to such transaction shall not
be a Fundamental Change pursuant to this clause (b); 
 (c) the stockholders of the Company approve any plan or proposal for
the liquidation or dissolution of the Company; or 
 (d) the Common Stock (or other common stock underlying the Notes) ceases
to be listed or quoted on any of The New York Stock Exchange, The NASDAQ Global Select Market or The NASDAQ Global Market (or any of their respective successors); 

provided, however, that a transaction or transactions described in clause (a) or clause (b) above shall not constitute a Fundamental
Change, if at least 90% of the consideration received or to be received by the ordinary shareholders of the Guarantor or the common stockholders of the Company, as applicable, excluding cash payments for fractional shares and cash payments made in
respect of dissenters’ rights, in connection with such transaction or transactions consists of shares of common stock that are listed or quoted on any of The New York Stock Exchange, The NASDAQ Global Select Market or The NASDAQ Global Market
(or any of their respective successors) or will be so listed or quoted when issued or exchanged in connection with such transaction or transactions and as a result of such transaction or transactions the Notes become convertible into such
consideration, excluding cash payments for fractional shares (subject to the provisions of Section 14.02(a)); and provided, further that any transaction that constitutes a Fundamental Change pursuant to both clause (a) and
clause (b) above shall be deemed a Fundamental Change solely under clause (b) above. 
 “Officer” means, with
respect to the Company or the Guarantor, the President, the Chief Executive Officer, Chief Medical Officer, Chief Commercial Officer, the Treasurer, the Secretary, any Executive or Senior Vice President or any Vice President (whether or not
designated by a number or numbers or word or words added before or after the title “Vice President”) thereof. 

“Officer’s Certificate,” when used with respect to the Company or the Guarantor, means a certificate that is delivered
to the Trustee and that is signed by an Officer of the Company or the Guarantor, as applicable. Each such certificate shall include the statements provided for in Section 17.05 if and to the extent required by the provisions of such Section.
The Officer giving an Officer’s Certificate pursuant to Section 4.08 shall be the principal executive, financial or accounting officer of the Company. 

ARTICLE 2 
 EFFECT OF MERGER ON
CONVERSION PRIVILEGE 
 Section 4.01. Conversion Right. From and after the Effective Time (as defined in the Merger Agreement),
each Holder of a Note that was outstanding as of the Closing shall have the right to convert each $1,000 principal amount of such Note into the amount of the Guarantor Common Stock that a holder of a number of shares of Company Common Stock equal to
the Conversion Rate immediately prior to such transaction would have owned or been entitled to receive, subject to the Company’s right to elect to pay cash upon such a conversion as provided in Section 14.02 of the Indenture. The Company
hereby declares that the amendments to Section 14.04 effected pursuant to this Article 2 provide for anti-dilution 

  
 5. 

 
and other adjustments with respect to events affecting the Guarantor Common Stock that are as nearly equivalent as is possible to the adjustments provided for in Article 14, prior to the
Effective Date, with respect to events affecting the Company Common Stock. 
 Section 4.02. Amendments to Article 14 of the
Indenture. Article 14 of the Indenture is hereby amended as follows: 
 (a) Section 14.01(b)(ii) of the Indenture is
hereby amended and restated in full to read as follows: 
 “(ii) If, prior to the close of business on the Business Day
immediately preceding August 15, 2018, the Guarantor elects to: 
 (A) issue to all or substantially all holders of the
Common Stock any rights, options or warrants (other than in connection with a stockholder rights plan) entitling them, for a period of not more than 45 calendar days after the declaration date for such issuance, to subscribe for or purchase shares
of the Common Stock at a price per share that is less than the average of the Last Reported Sale Prices of the Common Stock for the 10 consecutive Trading Day period ending on, and including, the Trading Day immediately preceding the declaration
date for such issuance; or 
 (B) distribute to all or substantially all holders of the Common Stock the Guarantor’s
assets, securities or rights to purchase securities of the Guarantor, which distribution has a per share value, as reasonably determined by the Board of Directors, exceeding 10% of the Last Reported Sale Price of the Common Stock on the Trading Day
preceding the date of announcement for such distribution, 
 then, in either case, the Company shall notify all Holders of the Notes, the
Trustee and the Conversion Agent (if other than the Trustee) at least 60 Scheduled Trading Days prior to the Ex-Dividend Date for such issuance or distribution. Once the Company has given such notice, a Holder may surrender all or any portion of its
Notes for conversion at any time until the earlier of (1) the close of business on the Business Day immediately preceding the Ex-Dividend Date for such issuance or distribution and (2) the Company’s announcement that such issuance or
distribution will not take place, in each case, even if the Notes are not otherwise convertible at such time. 
 (b)
Section 14.01(b)(iii) of the Indenture is hereby amended and restated in full to read as follows: 
 “(iii) If
(x) a transaction or event that constitutes a Fundamental Change or a Make-Whole Fundamental Change occurs prior to the close of business on the Business Day immediately preceding August 15, 2018, regardless of whether a Holder has the
right to require the Company to repurchase the Notes pursuant to Section 15.02, or (y) the Guarantor or the Company is a party to a consolidation, merger, binding share exchange, or transfer or lease of all or substantially all of its
consolidated assets prior to the close of business on the Business Day immediately preceding August 15, 2018 pursuant to which the Common Stock would be converted into cash, securities or other assets, then, in each case, all or any portion of
a Holder’s Notes may be surrendered for conversion at any time from or after the effective date of the transaction or event until 35 Trading Days after the effective date of such transaction or event (or, if later, until 35 Trading Days after
notice of the effective date of such transaction or event is given following the occurrence of such transaction or event) or, if such transaction or event also constitutes a Fundamental Change, until the related Fundamental Change Repurchase Date.
The 

  
 6. 

 
Company shall notify Holders, the Trustee and the Conversion Agent (if other than the Trustee) within three Business Days of the occurrence of such transaction or event.” 

(c) Section 14.02(c) of the Indenture is hereby amended and restated in full to read as follows: 

“(c) A Note shall be deemed to have been converted immediately prior to the close of business on the date (the
“Conversion Date”) that the Holder has complied with the requirements set forth in subsection (b) above. The Company shall pay or cause to be delivered, as the case may be, the consideration due in respect of the Conversion
Obligation on the third Business Day immediately following the relevant Conversion Date, if the Company elects Physical Settlement (provided that, with respect to any Conversion Date occurring on or after August 15, 2018, the Company shall
cause to be settled any such conversion on the Maturity Date), or on the third Business Day immediately following the last Trading Day of the relevant Observation Period, in the case of any other Settlement Method. If any shares of Common Stock are
due to converting Holders, the Company shall cause to be issued and delivered to the Conversion Agent or to such Holder, or such Holder’s nominee or nominees, certificates or a book-entry transfer through the Depositary for the full number of
shares of Common Stock to which such Holder shall be entitled in satisfaction of the Company’s Conversion Obligation. 

Notwithstanding anything to the contrary in the Indenture, to the extent any conversion of a Note is to be settled by delivery
of Common Stock, the Guarantor will deliver such shares of Common Stock to the applicable Holder. The exercise by a Holder of its right to require conversion of any of its Notes in compliance with the provisions of the Indenture shall be deemed to
constitute a demand for immediate repayment by the Company of such Notes. Any such delivery by the Guarantor of shares of Common Stock in settlement of the Conversion Obligations with respect to a Note will be deemed made in exchange of satisfaction
of the Guarantor’s Guarantee Obligations in respect of such Note and, as a result of such delivery, the Company will incur a debt for an equivalent amount owing to the Guarantor.” 

(d) Sections 14.04(a), 14.04(b), 14.04(c), 14.04(d), 14.04(e), 14.04(j), 14.04(m), 14.08(a), 14.10 and 14.11 of the Indenture
shall be amended to replace references to “the Company” with references to “the Guarantor.” 
 (e)
Section 14.06 of the Indenture is hereby amended and restated in full to read as follows: 
 “Section 14.06.
Shares to Be Fully Paid. The Guarantor shall provide, free from preemptive rights, out of its authorized but unissued shares or shares held in treasury, sufficient shares of Common Stock to provide for conversion of the Notes from time to
time as such Notes are presented for conversion (assuming that at the time of computation of such number of shares, all such Notes would be converted by a single Holder and that Physical Settlement is applicable).” 

(f) The first paragraph of Section 14.07(a) of the Indenture is hereby amended and restated in full to read as follows:

 “(a) In the case of: 

(i) any recapitalization, reclassification or change of the Common Stock (other than changes resulting from a share split or
combination), 

  
 7. 

 (ii) any consolidation, merger or combination involving the Company or the
Guarantor, 
 (iii) any sale, lease or other transfer to a third party of the consolidated assets of the Guarantor and the
Guarantor’s Subsidiaries substantially as an entirety or the consolidated assets of the Company and the Company’s Subsidiaries substantially as an entirety, or 

(iv) any statutory share exchange, 

in each case, as a result of which the Common Stock would be converted into, or exchanged for, stock, other securities, other property or
assets (including cash or any combination thereof) (any such event, a “Merger Event”), then, at and after the effective time of such Merger Event, the right to convert each $1,000 principal amount of Notes shall be changed into a
right to convert such principal amount of Notes into the kind and amount of shares of stock, other securities or other property or assets (including cash or any combination thereof) that a holder of a number of shares of Common Stock equal to the
Conversion Rate immediately prior to such Merger Event would have owned or been entitled to receive (the “Reference Property,” with each “unit of Reference Property” meaning the kind and amount of Reference Property
that a holder of one share of Common Stock is entitled to receive) upon such Merger Event and, prior to or at the effective time of such Merger Event (other than with respect to a Merger Event in which the Reference Property consists solely of
Common Stock), the Company, purchasing Person or the Successor Company, as the case may be, shall execute with the Trustee a supplemental indenture permitted under Section 10.01(f) providing for such change in the right to convert each $1,000
principal amount of Notes; provided, however, that at and after the effective time of the Merger Event (A) the Company, purchasing Person or Successor Company, as the case may be, shall continue to have the right to determine the
form of consideration to be paid or delivered, as the case may be, upon conversion of Notes in accordance with Section 14.02 and (B) (I) any amount payable in cash upon conversion of the Notes in accordance with Section 14.02
shall continue to be payable in cash, (II) any shares of Common Stock that the Company would have been required to deliver upon conversion of the Notes in accordance with Section 14.02 shall instead be deliverable in the amount and type of
Reference Property that a holder of that number of shares of Common Stock would have received in such Merger Event and (III) the Daily VWAP shall be calculated based on the value of a unit of Reference Property that a holder of one share of Common
Stock would have received in such Merger Event.” 
 ARTICLE 3 

PARENT GUARANTEE 

Section 3.01. Guarantee. 

(a) Subject to the provisions of this Article 3, the Guarantor hereby unconditionally guarantees to each Holder and its successors and assigns
that: (x) the principal of (including the Fundamental Change Repurchase Price), the Conversion Obligation with respect to, and interest and Additional Interest, if any, on the Notes shall be duly and punctually paid in full and/or performed in
accordance with the terms of the Indenture when due, whether at the Maturity Date, upon declaration of acceleration, upon required repurchase, upon conversion or otherwise, and interest on overdue principal and (to the extent permitted by law) any
interest, if any, on the Notes and (y) in case of any extension of time of payment or renewal of any Notes or any of such other obligations, the same shall be promptly paid in full when due or performed in accordance with the terms of the
extension or renewal, whether at the Maturity Date, by 

  
 8. 

 
acceleration, required repurchase, conversion or otherwise. Furthermore, subject to the provisions of this Article 3, the Guarantor hereby unconditionally guarantees to the Trustee and to each
Holder and their respective successors and assigns that (z) all other obligations of the Company to the Holders or the Trustee hereunder or under the Notes (including fees, expenses or other) shall be promptly paid in full or performed, all in
accordance with the terms hereof, subject, however, in the case of clauses (x), (y) and (z) above, to the limitations set forth in Section 3.02 hereof (the obligations set forth in this Section 3.01 collectively, the
“Guarantee Obligations”). The Guarantee constitutes a general unsecured and unsubordinated obligation of the Guarantor. 

Failing payment when due of any amount so guaranteed or any performance so guaranteed for whatever reason, the Guarantor will be obligated to
pay or perform the same immediately. The Guarantor agrees that this is a guarantee of payment and not a guarantee of collection. 
 (b) The
Guarantor hereby agrees that its obligations hereunder are unconditional, irrespective of the validity, regularity or enforceability of the Notes or this Indenture, the absence of any action to enforce the same, any waiver or consent by any Holder
with respect to any provisions hereof or thereof, the recovery of any judgment against the Company, any action to enforce the same or any other circumstance which might otherwise constitute a legal or equitable discharge or defense of a guarantor.
The Guarantor hereby waives diligence, presentment, demand of payment, filing of claims with a court in the event of insolvency or bankruptcy of the Company, any right to require a proceeding first against the Company, protest, notice and all
demands whatsoever and covenants that this Note Guarantee will not be discharged except by complete performance of the obligations contained in the Notes or this Indenture. 

(c) If any Holder or the Trustee is required by any court or otherwise to return to the Company, the Guarantor or any custodian, trustee,
liquidator or other similar official acting in relation to either the Company or the Guarantor, any amount paid by either to the Trustee or such Holder, this Note Guarantee, to the extent theretofore discharged, will be reinstated in full force and
effect. 
 (d) The Guarantor agrees that it will not be entitled to any right of subrogation in relation to the Holders in respect of any
obligations guaranteed hereby until payment in full of all obligations guaranteed hereby. The Guarantor further agrees that, as between the Guarantor, on the one hand, and the Holders and the Trustee, on the other hand, (1) the maturity of the
obligations guaranteed hereby may be accelerated as provided in Section 6.02 of the Indenture for the purposes of this Note Guarantee, notwithstanding any stay, injunction or other prohibition preventing such acceleration in respect of the
obligations guaranteed hereby, and (2) in the event of any declaration of acceleration of such obligations as provided in Section 6.02 of the Indenture, such obligations (whether or not due and payable) will forthwith become due and
payable by the Guarantor for the purpose of this Note Guarantee. 
 (e) This Note Guarantee shall remain in full force and effect and
continue to be effective should any petition be filed by or against the Company for liquidation, reorganization, should the Company become insolvent or make an assignment for the benefit of creditors or should a receiver or trustee be appointed for
all or any significant part of the Company’s assets, and shall, to the fullest extent permitted by law, continue to be effective or be reinstated, as the case may be, if at any time payment and performance of the Notes are, pursuant to
applicable law, rescinded or reduced in amount, or must otherwise be restored or returned by any obligee on the Notes or the Note Guarantee, whether as a “voidable preference,” “fraudulent transfer” or otherwise, all as though
such payment or performance had not been made. In the event that any payment or any part thereof, is rescinded, reduced, restored or returned, the Notes shall, to the fullest extent permitted by law, be reinstated and deemed reduced only by such
amount paid and not so rescinded, reduced, restored or returned. 

  
 9. 

 (f) In case any provision of this Note Guarantee shall be invalid, illegal or unenforceable, the
validity, legality and enforceability of the remaining provisions shall not in any way be affected or impaired thereby. 
 (g) Each payment
to be made by the Guarantor in respect of the Note Guarantee shall be made without set-off, counterclaim, reduction or diminution of any kind or nature. 

(h) The Company and the Guarantor acknowledge that the allotment, issuance and delivery of shares of Common Stock, if any, hereunder (whether
upon exchange, under the terms of the Note Guarantee or otherwise) by the Guarantor at the direction of, the Issuer will create an equivalent debt owing from the Company to the Guarantor. 

Section 3.02. Limitation on Guarantor Liability. The Guarantor, and by its acceptance of this Note Guarantee, each Holder, hereby
confirms that it is the intention of all such parties that this Note Guarantee of the Guarantor not constitute a fraudulent transfer or conveyance for purposes of any bankruptcy, insolvency or other similar law now or hereafter in effect, the
Uniform Fraudulent Conveyance Act, the Uniform Fraudulent Transfer Act or any similar federal or state law to the extent applicable to this Note Guarantee. To effectuate the foregoing intention, the Trustee, the Holders and the Guarantor hereby
irrevocably agree that the obligations of the Guarantor will be limited to the maximum amount that will, after giving effect to such maximum amount and all other contingent and fixed liabilities of the Guarantor that are relevant under such laws,
result in the obligations of the Guarantor under the Note Guarantee not constituting a fraudulent transfer or conveyance under applicable local law. 

Section 3.03. Notation Not Required. The Guarantor hereby agrees that the Note Guarantee set forth in Section 3.01 hereof
will remain in full force and effect notwithstanding any failure to endorse on each Note a notation of the Note Guarantee. 

Section 3.04. Release of Note Guarantee. Upon the satisfaction and discharge of the Indenture in accordance with Article 3 of the
Indenture, the Guarantor will be released and relieved of any obligations under the Note Guarantee. 
 Section 3.05.
Subrogation. The Guarantor shall be subrogated to all rights of Holders against the Company in respect of any amounts paid by the Guarantor pursuant to the provisions of Section 3.01; provided that, if an Event of Default has occurred
and is continuing, the Guarantor shall not be entitled to enforce or receive any payments arising out of, or based upon, such right of subrogation until all amounts then due and payable by the Company under this Indenture or the Notes shall have
been paid in full. 
 Section 3.06. Benefits Acknowledged. The Guarantor acknowledges that it will receive direct and indirect
benefits from the financing arrangements contemplated by the Indenture and that the guarantee and waivers made by it pursuant to the Note Guarantee are knowingly made in contemplation of such benefits. 

ARTICLE 4 
 MISCELLANEOUS 

Section 4.01. Ratification of Indenture. The Indenture, as supplemented by this Supplemental Indenture, is in all respects
ratified and confirmed, and this Supplemental Indenture shall be deemed part of the Indenture in the manner and to the extent herein and therein provided. 

  
 10. 

 Section 4.02. Trustee Not Responsible for Recitals. The recitals herein contained are
made by the Company and Guarantor and not by the Trustee, and the Trustee assumes no responsibility for the correctness thereof. The Trustee makes no representation as to the validity or sufficiency of this Supplemental Indenture. All of the
provisions contained in the Indenture in respect of the rights, privileges, immunities, powers, and duties of the Trustee shall be applicable in respect of the Supplemental Indenture as fully and with like force and effect as though fully set forth
in full herein. 
 Section 4.03 Addresses for Notices, Etc. Any notice or demand that by any provision of the Indenture or this
Supplemental Indenture is required or permitted to be given or served by the Trustee or by the Holders on the Guarantor shall be deemed to have been sufficiently given or made, for all purposes if given or served by being deposited postage prepaid
by registered or certified mail in a post office letter box addressed (until another address is filed by the Guarantor with the Trustee) to Horizon Pharma, Inc., 520 Lake Cook Road, Suite 520, Deerfield, Illinois 60015, Attention: General Counsel.

 Section 4.04. Governing Law. THIS SUPPLEMENTAL INDENTURE, THE INDENTURE, THE NOTE GUARANTEE AND EACH NOTE, AND ANY CLAIM,
CONTROVERSY OR DISPUTE ARISING UNDER OR RELATED TO THIS SUPPLEMENTAL INDENTURE, THE INDENTURE, THE NOTE GUARANTEE AND EACH NOTE, SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK (WITHOUT REGARD TO THE
CONFLICTS OF LAWS PROVISIONS THEREOF). 
 Section 4.05. Execution in Counterparts. This Supplemental Indenture may be executed
in any number of counterparts, each of which shall be an original, but such counterparts shall together constitute but one and the same instrument. The exchange of copies of this Supplemental Indenture and of signature pages by facsimile or PDF
transmission shall constitute effective execution and delivery of this Supplemental Indenture as to the parties hereto and may be used in lieu of the original Supplemental Indenture for all purposes. Signatures of the parties hereto transmitted by
facsimile or PDF shall be deemed to be their original signatures for all purposes. 
 Section 4.06. Effectiveness. This
Supplemental Indenture shall not be effective until, and shall become effective upon, without further action by the parties hereto, the Effectiveness Time as defined under the Merger Agreement. 

[Signature Page Follows] 

  
 11. 

 IN WITNESS WHEREOF, the parties hereto have caused this Supplemental Indenture to be duly
executed as of the day and year first above written. 
  

			
	HORIZON PHARMA, INC.
		
	By:	 	 /s/ Robert J. De Vaere

		 	Name: Robert J. De Vaere
		 	 Title: Executive Vice President,
 Chief
Financial Officer and Secretary

	
	 HORIZON PHARMA PUBLIC
 LIMITED
COMPANY

		
	By:	 	 /s/ David Kelly

		 	Name: David Kelly
		 	Title: Chief Accounting Officer
	
	 U.S. BANK NATIONAL
 ASSOCIATION, as
Trustee

		
	By:	 	 /s/ Raymond S. Haverstock

		 	Name: Raymond S. Haverstock
		 	Title: Vice President

 SIGNATURE PAGE TO SUPPLEMENTAL INDENTURE

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00235-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00235-of-00352.parquet"}]]